- Exchange: Stuttgart
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Products
Eckert-Ziegler Bebig
+ Add to WatchlistIBY:GR
1.921 EUR 0.059 3.17%As of 02:10:53 ET on 05/22/2013.
Snapshot for Eckert-Ziegler Bebig (IBY)
| Open: | 1.921 | Day's Range: | 1.921 - 1.921 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 1.862 | 52wk Range: | 1.310 - 2.455 | 1-Yr Rtn: | +26.97% |
Key Statistics for IBY
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2012) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS (12/2012) | - |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 0 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/15/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for IBY
No data available
Company Profile & Key Executives for IBY
Eckert-Ziegler Bebig manufactures and markets radioactive implants and medications used in the treatment of cancer. The Company's implants are a localized treatment that kills the cancer without damaging the surrounding tissues. Eckert & Ziegler BEBIG has a worldwide network of distributors and agents to support the international marketing of its product line.
| Edgar LoefflerJoint Managing Director | Abel LuzuriagaJoint Managing Director |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
IBY News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page